• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Retraction Note to: The Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Molecularly Selected Patients with Non-Small Cell Lung Cancer: A Meta-Analysis of 30 Randomized Controlled Trials.

作者信息

Liu Jin, Sheng Zhixin, Zhang Yanxia, Li Guixin

机构信息

Shandong University, Jinan, Shandong, China.

Department of Hematology, Weifang People's Hospital, Weifang, China.

出版信息

Target Oncol. 2016 Dec;11(6):837. doi: 10.1007/s11523-016-0468-z.

DOI:10.1007/s11523-016-0468-z
PMID:27896575
Abstract
摘要

相似文献

1
Retraction Note to: The Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Molecularly Selected Patients with Non-Small Cell Lung Cancer: A Meta-Analysis of 30 Randomized Controlled Trials.对《表皮生长因子受体酪氨酸激酶抑制剂对分子筛选的非小细胞肺癌患者的疗效：30项随机对照试验的荟萃分析》的撤稿说明
Target Oncol. 2016 Dec;11(6):837. doi: 10.1007/s11523-016-0468-z.
2
The Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Molecularly Selected Patients with Non-Small Cell Lung Cancer: A Meta-Analysis of 30 Randomized Controlled Trials.表皮生长因子受体酪氨酸激酶抑制剂对分子筛选的非小细胞肺癌患者的疗效：30项随机对照试验的荟萃分析。
Target Oncol. 2016 Feb;11(1):49-58. doi: 10.1007/s11523-015-0376-7.
3
Factors associated with efficacy of first-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer.第一代表皮生长因子受体酪氨酸激酶抑制剂治疗非小细胞肺癌疗效的相关因素
Tumour Biol. 2017 May;39(5):1010428317705340. doi: 10.1177/1010428317705340.
4
The Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Harboring Wild-type Epidermal Growth Factor Receptor: A Meta-analysis of 25 RCTs.表皮生长因子受体酪氨酸激酶抑制剂对野生型表皮生长因子受体非小细胞肺癌的疗效：25项随机对照试验的荟萃分析
Am J Clin Oncol. 2017 Aug;40(4):362-369. doi: 10.1097/COC.0000000000000179.
5
The Efficacy of Single-Agent Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Biologically Selected Patients with Non-Small-Cell Lung Cancer: A Meta-Analysis of 19 Randomized Controlled Trials.单药表皮生长因子受体酪氨酸激酶抑制剂治疗生物学特征选择的非小细胞肺癌患者的疗效：19项随机对照试验的荟萃分析
Chemotherapy. 2016;61(4):179-89. doi: 10.1159/000442344. Epub 2016 Feb 10.
6
Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: focus on epidermal growth factor receptor mutation testing and mutation-positive patients.表皮生长因子受体酪氨酸激酶抑制剂作为非小细胞肺癌的初始治疗：重点关注表皮生长因子受体突变检测和突变阳性患者。
Cancer Treat Rev. 2013 Dec;39(8):839-50. doi: 10.1016/j.ctrv.2013.05.001. Epub 2013 Jun 12.
7
The role of smoking status on the progression-free survival of non-small cell lung cancer patients harboring activating epidermal growth factor receptor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor versus platinum doublet chemotherapy: a meta-analysis of prospective randomized trials.吸烟状态对携带激活型表皮生长因子受体（EGFR）突变的非小细胞肺癌患者一线接受EGFR酪氨酸激酶抑制剂与铂类双联化疗的无进展生存期的影响：前瞻性随机试验的荟萃分析
Oncologist. 2015 Mar;20(3):307-15. doi: 10.1634/theoncologist.2014-0285. Epub 2015 Feb 5.
8
Epidermal growth factor receptor tyrosine kinase inhibitors vs conventional chemotherapy in non-small cell lung cancer harboring wild-type epidermal growth factor receptor: a meta-analysis.表皮生长因子受体酪氨酸激酶抑制剂与野生型表皮生长因子受体非小细胞肺癌的传统化疗：荟萃分析。
JAMA. 2014 Apr 9;311(14):1430-7. doi: 10.1001/jama.2014.3314.
9
Epidermal growth factor receptor-tyrosine kinase inhibitors in advanced squamous cell carcinoma of the lung: a meta-analysis.表皮生长因子受体-酪氨酸激酶抑制剂治疗晚期肺鳞状细胞癌的荟萃分析
Asia Pac J Clin Oncol. 2014 Sep;10(3):273-8. doi: 10.1111/ajco.12231.
10
Is There a Survival Benefit of First-Line Epidermal Growth Factor Receptor Tyrosine-Kinase Inhibitor Monotherapy Versus Chemotherapy in Patients with Advanced Non-Small-Cell Lung Cancer?: A Meta-Analysis.一线表皮生长因子受体酪氨酸激酶抑制剂单药治疗与化疗相比，对晚期非小细胞肺癌患者是否有生存获益？一项荟萃分析。
Target Oncol. 2016 Feb;11(1):41-7. doi: 10.1007/s11523-015-0373-x.

引用本文的文献

1
Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer.原发性乳腺癌中程序性细胞死亡受体 1（PD-1）和程序性死亡配体 1（PD-L1）基因的表达。
Breast Cancer Res Treat. 2021 Jun;187(2):387-395. doi: 10.1007/s10549-021-06234-3. Epub 2021 Apr 28.